title: Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression.
abstract: Low molecular weight (LMW) isoforms of cyclin E are post-translationally generated in breast cancer cells and are associated with aggressive disease and poor prognosis. In this study, the specificity of LMW cyclin E to cancer cells was determined by measuring cyclin E expression in tumor and non-tumor tissue from 340 breast cancer patients. Our results reveal the LMW isoforms were detected significantly more frequently in breast tumor tissue than in adjacent non-tumor breast tissues (p < 0.0001). The biologic consequences of the LMW isoforms were studied using a non-tumorigenic mammary epithelial cell line transfected with the cyclin E isoforms and resulted in increased clonogenicity, the inability to enter quiescence in response to growth factor deprivation and genomic instability compared to the full-length cyclin E. Biochemical differences between the full-length and the LMW isoforms were also evident. Biacore analyses show that the LMW isoforms have more efficient binding to CDK2 compared to full-length cyclin E, which could account for the unique biologic consequences observed with the expression of LMW cyclin E. The LMW isoforms of cyclin E are tumor specific, and are biochemically and biologically distinct from the full-length cyclin E which could provide a novel role in breast cancer progression.
authors.affiliation: Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
authors.forename: Hannah
authors.initials: H
authors.lastname: Wingate
authors.forename: Agnes
authors.initials: A
authors.lastname: Puskas
authors.forename: Mylinh
authors.initials: M
authors.lastname: Duong
authors.forename: Tuyen
authors.initials: T
authors.lastname: Bui
authors.forename: Dana
authors.initials: D
authors.lastname: Richardson
authors.forename: Yanna
authors.initials: Y
authors.lastname: Liu
authors.forename: Susan L
authors.initials: SL
authors.lastname: Tucker
authors.forename: Carolyn
authors.initials: C
authors.lastname: Van Pelt
authors.forename: Laurent
authors.initials: L
authors.lastname: Meijer
authors.forename: Kelly
authors.initials: K
authors.lastname: Hunt
authors.forename: Khandan
authors.initials: K
authors.lastname: Keyomarsi
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D001940:Breast / Q000378:metabolism*; D001943:Breast Neoplasms / Q000378:metabolism*; D002869:Chromosome Aberrations; D019927:Cyclin E / Q000378:metabolism*; D051357:Cyclin-Dependent Kinase 2 / Q000378:metabolism; D005260:Female; D042822:Genomic Instability; D006801:Humans; D020033:Protein Isoforms / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D019927:Cyclin E; D020033:Protein Isoforms; C495894:CDK2 protein, human; D051357:Cyclin-Dependent Kinase 2